Hemangiosarcoma - a cancer of the vascular endothelium

While I understand that other compounds have been more targeted at cancers -

I just had to wonder . . . . even as an adjuvant treatment - certainly inflammation is a big problem in cancers.

In very simple terms - I do get that there are other prioritized targets right now, and that just because it is in the same organ system doesn't mean it is relevant to everything that can go wrong there  - but like I said - still had to wonder. Has anyone ever mentioned or thought about this as a possible treatment or even ruled it out as not likely to be helpful? And if so - what would be your reasoning?

For me personally, such digressions ease the sting of the long wait and  -in my case still losses with this investment. But I still want them to succeed. Bag-holder all the way.

Thanks.